SCHEMBL16743500

SCHEMBL16743500

Nc1ncnc2c1ccn2[C@H]1CC(OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)CC2O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.63
P2RY1 P47900 4/20 0.58
ENPP1 P22413 3/20 0.58
RNASEL Q05823 1/20 0.56
P2RX1 P51575 3/20 0.56
P2RX3 P56373 3/20 0.56
P2RX2 Q9UBL9 2/20 0.56
DTYMK P23919 2/20 0.54
P2RY2 P41231 2/20 0.53
P2RX4 Q99571 2/20 0.53
SRC P12931 1/20 0.53
ALDH1A1 P00352 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MACROD2 A1Z1Q3 1/20 0.51
SIRT6 Q8N6T7 1/20 0.51
MACROD1 Q9BQ69 1/20 0.51
TRPM2 O94759 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16743926 1.00 POLB (0.63) POLBP2RY1ENPP1RNASELP2RX1
SCHEMBL10034040 0.93 POLB (0.72) POLBP2RY1ENPP1RNASELP2RX1
SCHEMBL17269644 0.93 POLB (0.60) POLBP2RY1ENPP1RNASELDTYMK
SCHEMBL17268345 0.93 POLB (0.60) POLBP2RY1ENPP1RNASELDTYMK
SCHEMBL29487848 0.89 POLB (0.58) POLBP2RY1ENPP1RNASELP2RX1
SCHEMBL889285 0.89 POLB (0.58) POLBP2RY1ENPP1RNASELP2RX1
SCHEMBL26031206 0.89 POLB (0.58) POLBP2RY1ENPP1RNASELP2RX1
SCHEMBL29382612 0.88 POLB (0.70) POLBP2RY1ENPP1RNASELP2RY2
SCHEMBL31454757 0.88 POLB (0.70) POLBP2RY1ENPP1RNASELP2RY2
SCHEMBL78250 0.88 POLB (0.80) POLBP2RY1ENPP1RNASELP2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150329864-A1 DESIGN OF OLIGONUCLEOTIDE ANALOGS AS THERAPEUTIC AGENTS SPRING BANK PHARMACEUTICALS, INC. (US) 2015-11-19 US disclosed
US-9040234-B2 Oligonucleotide analogs as therapeutic agents SPRING BANK PHARMACEUTICALS, INC. (US) 2015-05-26 US disclosed